As blockbuster GLP-1 injectables like Mounjaro, Wegovy and Ozempic gain traction in India, doctors stress that careful ...

Expert Dr. Salas-Whalen reveals that body composition testing, not just the number on your scale, is key to knowing whether GLP-1 weight-loss medications are right for you.

Despite the definitive failure of Novo Nordisk’s semaglutide in Alzheimer’s, biotech executives, analysts and other industry ...

At-home health testing platform Ash is expanding its partnership with weight-loss company Noom to bring Noom's Proactive Health Microdose GLP-1Rx Program to market. Noom's program, launched in August, ...

Studies presented at Obesity Week 2025 validate the test's ability to predict weight-loss response to GLP-1 drugs like semaglutide, including in diverse patient populations and post-bariatric surgery ...

Novo Nordisk (NVO) plans to run studies on how its GLP-1 class of weight loss/diabetes drug can help people deal with ...

Researchers are studying whether these widely used weight-loss drugs may also be future treatments for alcohol abuse.

GLP-1 drugs such as Ozempic and Mounjaro are a revolution, not a trend. These weight loss drugs are one of the hottest markets in healthcare, and there’s been a dramatic surge in the number of ...

A pharmaceutical company has begun testing the first GLP-1 weight-loss therapy designed specifically for cats. The implant, called OKV-119, slowly releases medication that may curb appetite and ...